Abstract-The normal expression of myocardial mitochondrial enzymes is essential to maintain the cardiac energy reserve and facilitate responses to stress, but the molecular mechanisms to maintain myocardial mitochondrial enzyme expression have been elusive. Here we report that congestive heart failure is associated with a significant decrease of myocardial estrogen-related receptor-␣ (ERR␣), but not peroxisome proliferator-activated receptor-␥ coactivator 1␣, in human heart failure samples. In addition, chronic pressure overload in mice caused a decrease of ERR␣ expression that was significantly correlated to the degree of left ventricular dysfunction, pulmonary congestion, and decreases of a group of myocardial energy metabolism-related genes. We found that the metabolic sensor AMP activated protein kinase (AMPK) regulates ERR␣ expression in vivo and in vitro. AMPK␣2 knockout decreased myocardial ERR␣ (both mRNA and protein) and its downstream targets under basal conditions, with no change in myocardial peroxisome proliferator-activated receptor-␥ coactivator 1␣ expression. Using cultured rat neonatal cardiac myocytes, we found that overexpression of constitutively active AMPK␣ significantly induced ERR␣ mRNA, protein, and promoter activity. Conversely, selective gene silencing of AMPK␣2 repressed ERR␣ and its target gene levels, indicating that AMPK␣2 is involved in the regulation of ERR␣ expression. In addition, overexpression of ERR␣ in AMPK␣2 knockout neonatal cardiac myocytes partially rescued the repressed expression of some energy metabolism-related genes. These data support an important role for AMPK␣2 in regulating the expression of myocardial ERR␣ and its downstream mitochondrial enzymes. T he normal expression of myocardial mitochondrial enzymes is essential to maintain cardiac energy reserve and facilitate compensatory responses to stress. During the past few years, significant progress has been made in understanding the basic molecular mechanism of mitochondrial biogenesis. Using genetically modified mice and cells, the biological significance of a group of transcriptional factors and coactivators that modulate mitochondrial function has been revealed. Estrogen-related receptor-␣ (ERR␣) is one of these transcriptional factors that plays an important role in regulating energy homeostasis and mitochondrial biogenesis. 1,2 ERR␣ is expressed at high levels in tissue that is using diet-derived lipid as fuel. 3 It has been demonstrated that ERR␣ induces pyruvate dehydrogenase kinase 2 and pyruvate dehydrogenase kinase 4 expression in hepatoma cells 4, 5 and skeletal muscle, 6 indicating that ERR␣ may promote fatty acid oxidation and repress glycolysis. Using ChIP-on-chip, Dufour et al 7 demonstrated that, in adult mouse hearts, ERR␣ and ERR␥ direct the activity of a set of genes that are implicated in intracellular fuel sensing, uptake of energy substrate, fatty acid oxidation and tricarboxylic acid cycle activity, transport of ATP across the mitochondrial membranes, and Ca 2ϩ handling. This suggests that ERR␣ is involved in a broad range of cardiac functions related to myocardial energetics. Consistent with these observations, Huss et al 8 demonstrated that ERR␣ deficiency caused decreased expression of several ERR␣ target genes involved in myocardial substrate use and energy production. This abnormal gene expression profile is responsible for the reduced high-energy phosphate reserve and lower ATP synthesis rate in response to an increased workload in ERR␣ null mice. 8 ERR␣ expression can be induced in human skeletal muscle by exercise, 9 in brown fat and skeletal muscle of mice by cold
T he normal expression of myocardial mitochondrial enzymes is essential to maintain cardiac energy reserve and facilitate compensatory responses to stress. During the past few years, significant progress has been made in understanding the basic molecular mechanism of mitochondrial biogenesis. Using genetically modified mice and cells, the biological significance of a group of transcriptional factors and coactivators that modulate mitochondrial function has been revealed. Estrogen-related receptor-␣ (ERR␣) is one of these transcriptional factors that plays an important role in regulating energy homeostasis and mitochondrial biogenesis. 1, 2 ERR␣ is expressed at high levels in tissue that is using diet-derived lipid as fuel. 3 It has been demonstrated that ERR␣ induces pyruvate dehydrogenase kinase 2 and pyruvate dehydrogenase kinase 4 expression in hepatoma cells 4, 5 and skeletal muscle, 6 indicating that ERR␣ may promote fatty acid oxidation and repress glycolysis. Using ChIP-on-chip, Dufour et al 7 demonstrated that, in adult mouse hearts, ERR␣ and ERR␥ direct the activity of a set of genes that are implicated in intracellular fuel sensing, uptake of energy substrate, fatty acid oxidation and tricarboxylic acid cycle activity, transport of ATP across the mitochondrial membranes, and Ca 2ϩ handling. This suggests that ERR␣ is involved in a broad range of cardiac functions related to myocardial energetics. Consistent with these observations, Huss et al 8 demonstrated that ERR␣ deficiency caused decreased expression of several ERR␣ target genes involved in myocardial substrate use and energy production. This abnormal gene expression profile is responsible for the reduced high-energy phosphate reserve and lower ATP synthesis rate in response to an increased workload in ERR␣ null mice. 8 ERR␣ expression can be induced in human skeletal muscle by exercise, 9 in brown fat and skeletal muscle of mice by cold exposure, 10 and in mouse liver by fasting. 11 However, little is known about regulation of ERR␣ expression in the heart and whether ERR␣ expression changes during the development of heart failure.
The metabolic sensor AMP activated protein kinase (AMPK) integrates signals regarding energy expenditure and energy production to regulate cellular metabolic processes. In response to metabolic stress, AMPK is rapidly activated to preserve energy homeostasis. During myocardial ischemia, AMPK activation increases glucose uptake, glycolysis, and fatty acid oxidation. 12 In mice subjected to left coronary artery occlusion/reperfusion, activation of AMPK by metformin significantly increased survival and improved ventricular function. 13 Conversely, adult male mice overexpressing a dominant-negative AMPK␣2 subunit exhibited greater injury after ischemia/reperfusion. 14,15 Both AMPK␣1 and AMPK␣2 activities were elevated in rat hearts subjected to pressure overload, implying that AMPK is involved in the response to chronic hemodynamic overload. 16, 17 Furthermore, our previous study using AMPK␣2-deficient mice demonstrated that AMPK exerts cardioprotective effects against systolic pressure overload-induced left ventricular hypertrophy and dysfunction partially by repressing mammalian target of rapamycin (mTOR) signaling. 16 The inhibition of mTOR signaling by AMPK may help to decrease energy consumption associated with mTOR-dependent increases in translation. However, whether AMPK is also involved in regulation of myocardial energy generation is not clear.
It has been reported that peroxisome proliferator activated receptor-␥ coactivator-1␣ (PGC-1␣) is the key regulator that controls cardiac energy metabolism. 18, 19 However, we found that the protein level of PGC-1␣ was unchanged in the failing human heart, whereas the protein content of ERR␣ was significantly decreased. Furthermore, the decrease of ERR␣ in response to chronic pressure overload in mouse hearts was significantly correlated with the decrease of left ventricular (LV) ejection fraction, increase of pulmonary congestion, and dysregulation of the expression of several energy metabolism-related genes. Using AMPK␣2 knockout (KO) mice, as well as by manipulating AMPK␣2 expression in isolated neonatal cardiomyocytes, we demonstrated that AMPK␣2 plays an important role in regulating ERR␣ promoter activity, mRNA and protein level, and ERR␣ downstream metabolic gene expression. These data indicate that AMPK␣2 not only plays an important role in regulating the myocardial mTOR signaling pathway, but that it also maintains cardiac energy levels and cardiac function through regulation of ERR␣ expression.
Materials and Methods
Please see the online Data Supplement at http://hyper.ahajournals. org for an expanded Material and Methods section.
Adult (12 to 15 weeks) male AMPK␣2-deficient mice (background of C57B6J) 20 and their wild-type littermates were used in this study. All of the animal studies were performed according to a protocol approved by the University of Minnesota Institutional Animal Care and Use Committee.
Results

Human Heart Failure Samples Show Decreased LV ERR␣ Expression But Unchanged PGC-1␣ Expression
We studied the expressions of LV ERR␣ and PGC-1␣ in 5 patients with chronic heart failure (CHF) and 5 normal donor hearts (Table S1 , available in the online Data Supplement). ERR␣ expression was significantly decreased by Ϸ40% in the CHF hearts as compared with the donor hearts ( Figure 1 ). Interestingly, the protein level of PGC-1␣, a well-defined transcriptional coactivator regulating energy metabolism and mitochondrial biogenesis, was not decreased. Myocardial ANP protein, a marker associated with ventricular hypertrophy and heart failure, was significantly increased in the CHF hearts. In addition, the myocardial mitochondrial respiratory chain components cytochrome C and fatty acid transporter CD36 were significantly decreased in the CHF samples ( Figure 1 ).
LV Dysfunction and Decreased Energy Metabolism-Related Gene Expression Are Correlated With Decreased Myocardial ERR␣ Expression
Because ERR␣ expression is decreased in human failing heart samples, we speculated that there might be a correlation between the repressed ERR␣ expression and the downregulation of fatty acid metabolism-related genes, as well as LV dysfunction. To test this hypothesis, wild-type mice were subjected to Figure 1 . Expression of estrogen-related receptor-␣ (ERR␣) and energy metabolism-related enzymes in failing human hearts. Western blots of human heart tissue samples (A). Myocardial ERR␣ was significantly decreased in the failing heart, which was associated with decreases in some mitochondrial enzymes (B). *PϽ0.05 as compared with normal donor hearts.
severe pressure overload using the transverse aortic constriction (TAC) procedure and LV samples from these mice were collected 2 weeks after TAC (when mice had moderate LV dysfunction) or 4 weeks after TAC (when mice had severe LV dysfunction). TAC caused a progressive increase of the ratio of ventricular weight:body weight ( Figure 2A ) and the ratio of lung weight:body weight ( Figure 2B ), a reliable marker of LV dysfunction. [21] [22] [23] TAC also caused increased LV end systolic diameter ( Figure 2C ) and a decrease of LV ejection fraction ( Figure 2D ). At 2 weeks after TAC, electron microscopy revealed no apparent mitochondrial damage. At 4 weeks after TAC, electron microscopy revealed swollen and vacuolated cristae in some cardiac myocyte mitochondria, with some mitochondria completely disrupted ( Figure S1 ). Hearts subjected to TAC demonstrated a gradual increase of ANP, as well as decreases of ERR␣ and energy metabolism-related genes, including cytochrome C, CD36, and medium chain acetyl-coenzyme A dehydrogenase (MCAD; Figure 2E and 2F). As in the human failing heart, myocardial PGC-1␣ expression was unchanged in the mice in response to pressure overload for 4 weeks of TAC. Thus, the decrease of LV ERR␣ was correlated with the decreased expression of energy metabolism-related genes and impaired cardiac function. These data suggest that the decreased expression of ERR␣, but not PGC-1␣, may be a marker of LV dysfunction. Because previous studies have demonstrated that ERR␣ gene deletion attenuates the expression of metabolism-related genes, such as MCAD and cytochrome C, and exacerbates TACinduced LV hypertrophy and dysfunction, 8 it is plausible that the decreased LV ERR␣ would contribute to the development of LV dysfunction in the pressure-overloaded heart.
AMPK␣2 Deficiency Attenuated Expression of Myocardial ERR␣ Protein and Energy Metabolism-Related Genes
Our previous study using AMPK␣2 null mice demonstrated that AMPK suppresses the energy consuming process of protein synthesis through mTOR signaling and attenuates cardiac hypertrophy induced by pressure overload. 16 Furthermore, we found that, in the AMPK␣2 null heart, the protein levels of several energy metabolism-related genes, including MCAD, carnitine palmityl transferase 1 muscle isoform (CPT1b), cytochrome C, and uncoupling protein 3, were significantly decreased as compared with their wild-type littermates ( Figure 3 ). In addition, the ERR␣ protein level was significantly reduced in AMPK␣2-deficient hearts, whereas the protein level of PGC-1␣ was similar between the wild-type and AMPK␣2 KOs ( Figure  3 ). Thus, depletion of AMPK␣2 attenuated the expression of mitochondrial enzymes involved in energy production. Similar to our observations in the human CHF samples and in the mouse hearts with pressure overload-induced hypertrophy, the repression of energy metabolism-related genes in the AMPK␣2-deficient heart was associated with decreased expression of ERR␣ but not PGC-1␣.
AMPK␣2 Regulates ERR␣ Gene Expression in Rat Neonatal Cardiac Myocytes
To be sure that the downregulation of ERR␣ in the AMPK␣2 KO mouse hearts was not attributed to neurohormonal alterations in the intact animal, we examined the regulation of ERR␣ by AMPK using rat neonatal cardiac myocytes. First, we inhibited AMPK␣2 expression in the cardiac myocytes using specific small interfering RNA. The expression of AMPK␣2 was decreased by 80%; the protein level of AMPK␣1 was not significantly changed ( Figure 4A and 4B). The phosphorylation of acetyl-CoA carboxylase, a substrate of AMPK, was significantly decreased, suggesting that AMPK␣2 is the dominant isoform in cardiac myocytes. Furthermore, decreasing the expression of AMPK␣2 significantly decreased the protein levels of ERR␣ and its targets, MCAD and CPT1b ( Figure 4A and 4B), suggesting that AMPK␣2 is required for maintaining normal expression levels of ERR␣ and its target genes. Consistent with the above observations, in rat neonatal cardiac myocytes, activation of AMPK with aminoimidazole carboxamide ribonucleotide (AICAR) caused an induction of ERR␣ protein 6 hours after AICAR treatment (please see Figure S2 ). Furthermore, overexpression of constitutively active AMPK␣ (gift from Dr Ming-Hui Zou, Section of Molecular Medicine, Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK) in rat neonatal cardiac myocytes caused significant increases of ERR␣, MCAD, and CPT1b ( Figure 4C and 4D) . Taken together, these data suggest that AMPK␣2 can regulate the expression of ERR␣ and its target genes.
AMPK␣2 Regulates Myocardial ERR␣ at the Transcriptional Level Both In Vivo and In Vitro
To understand the mechanism of ERR␣ gene regulation by AMPK␣2, reverse transcription and real-time PCR was performed to determine the mRNA contents of ERR␣ and its target genes in the AMPK␣2-deficient mice and their wildtype littermates. AMPK␣2 gene deletion significantly decreased the mRNA levels of ERR␣, very long chain acetyl CoA dehydrogenase (VLCAD), MCAD, CPT1b, cytochrome C oxidase I, and cytochrome C oxidase III ( Figure S3A ). Interestingly, the mRNA level of PGC-1␣ was significantly increased in the AMPK␣2-deficient hearts. This result suggested that PGC-1␣ was not directly involved in the downregulation of the mitochondrial enzymes caused by AMPK␣2 depletion.
In rat neonatal cardiac myocytes, selective gene silencing of AMPK␣2 by specific small interfering RNA caused significant reductions in the mRNA levels of ERR␣ and VLCAD ( Figure S3B ). There was a trend toward downregulation of CPT1b, but this was not significant. Thus, both the in vivo and in vitro data suggest that AMPK␣2 can regulate ERR␣ expression at the transcriptional level.
To test whether AMPK␣2 can regulate ERR␣ promoter activity, a reporter construct driven by 3.5 kb of the ERR␣ promoter was transfected into rat neonatal cardiac myocytes, and the cells were treated with AICAR for 24 hours. As shown in Figure 5A , treatment with AICAR dosedependently increased reporter gene activity. Conversely, ablation of AMPK␣2 expression by specific small interfering RNA caused a significant decrease of the reporter gene activity in vehicle-treated cells and also repressed its activation by AICAR ( Figure 5B ). These results indicate that the induction of ERR␣ promoter activity by AICAR is AMPK␣2 dependent and suggest that AMPK regulates ERR␣ expression at the transcriptional level. The induction of reporter activity by AICAR was slightly decreased but still observed when the reporter was driven by only Ϸ400 bp of the ERR␣ promoter ( Figure 5C ). This 400 bp of the mouse ERR␣ promoter contains multiple Sp1 sites, which are conserved in humans ( Figure 5C ). 24 Chromatin immunoprecipitation assay using rat neonatal cardiac myocytes demonstrated that Sp1 was recruited to this region and that treatment with AICAR enhanced the interaction between Sp1 and the ERR␣ promoter ( Figure  5D ). Indeed, knocking down the expression of Sp1 in rat neonatal cardiac myocytes repressed basal ERR␣ promoter activity and its induction by AICAR ( Figure 5E ), which resulted in decreased ERR␣ expression at the protein level ( Figure 5F ). Thus, Sp1 is involved in AMPK regulation of ERR␣.
Overexpression of ERR␣ or Constitutively Active AMPK Partially Rescued Energy Metabolism-Related Gene Expression in AMPK␣2-Deficient Mice
AMPK␣2 deficiency resulted in a significant decrease of myocardial ERR␣ at both mRNA and protein levels. Furthermore, the phenotype and gene expression profile of AMPK␣2 KO mice are similar to those of the ERR␣ KO mice. Therefore, downregulation of ERR␣ might contribute to the abnormal myocardial energy metabolism-related gene expression in the AMPK␣2 KO mice. To test this hypothesis, neonatal cardiac myocytes were isolated from wild-type and AMPK␣2-deficient mice and infected with adenovirus overexpressing either constitutively active AMPK␣ or ERR␣. Overexpression of constitutively active AMPK␣ significantly increased the mRNA levels of the ERR␣ target genes, VLCAD, MCAD, and CPT1b, in both wild-type and AMPK␣2 KO cells ( Figure 6 ). In the wild-type cells where ERR␣ levels were normal, increasing ERR␣ expression caused an increase of VLCAD mRNA but had no effect on the expression of MCAD and even repressed the expression of CPT1b. Thus, other factors, such as the levels of coregulators, may influence the function of ERR␣. In the AMPK␣2-deficient cells, where ERR␣ expression is reduced, overexpression of ERR␣ increased the mRNA levels of VLCAD and MCAD. These data indicate that overexpression of ERR␣ was able to partially rescue the repressed expression of the energy metabolism-related enzymes in the AMPK␣2-deficient cardiac myocytes.
Previous studies have shown that activation of AMPK by metformin protects cardiac myocytes from oxidative stressinduced cell death. 25 Indeed, when we treated rat neonatal cardiac myocytes with H 2 O 2 , AMPK␣2-specific gene silencing caused a decrease of cell viability and an increase of cleaved caspase 3 and TUNEL-positive cells (please see Figure S4 ). Furthermore, the increased vulnerability to oxidative stress damage caused by AMPK␣2 knockdown was partially rescued by overexpression of ERR␣ (please see Figure S4 ). The finding that AMPK/ERR␣ is involved in the protection of cardiac myocytes against oxidative stress is in agreement with the report that ERR␣ plays a critical role in the expression of antioxidant genes in embryonic fibroblasts. 26 
Discussion
Dysregulation of energy metabolism-related genes is an important aspect in the development of pathological ventricular hypertrophy and heart failure. In human heart failure samples, we found that ERR␣ protein levels were decreased, and this was associated with downregulation of several enzymes that are involved in energy production, whereas the protein level of PGC-1␣ was not changed. Similarly, we observed significant downregulation of ERR␣ and several energy metabolism-related genes in mouse ventricular tissue after 4 weeks of TAC, with no alterations of PGC-1␣ at the protein level. These findings support the concept that the expression of ERR␣ is of vital importance in preserving energy production and cardiac function under stress conditions. 27 Detailed studies by Dr Teng's group 24, 28, 29 identified a multihormone response element and multiple Sp1 sites in the ERR␣ promoter and demonstrated that the transcription of ERR␣ can be modulated by ERR␣, ERR␥, estrogen receptor, and Sp1. In the current study, we demonstrated for the first time that AMPK␣2 contributes to the regulation of myocardial ERR␣ expression. Several lines of evidence suggested that AMPK␣2 is one of the regulators of myocardial ERR␣ expression. First, selective gene silencing of AMPK␣2 in rat neonatal cardiac myocytes repressed ERR␣ expression. Similarly, under basal conditions, depletion of AMPK␣2 in the KO mice resulted in decreased ERR␣ at both mRNA and protein levels. Thus, AMPK␣2 can regulate ERR␣ expression under physiological conditions. Second, activation of AMPK with AICAR or overexpression of constitutively active AMPK in rat neonatal cardiac myocytes induced ERR␣ promoter activity and expression. This induction was blunted by knocking down the expression of AMPK␣2. We further demonstrated that Sp1 is involved in the regulation of ERR␣ by AMPK. In addition to regulating ERR␣ expression, AMPK may also influence ERR␣ function by adjusting its subcellular distribution. 30 In addition to ERR␣, several energy metabolism-related genes, including CPT1b, MCAD, VLCAD, CD36, and uncoupling protein 3, were also increased in response to activation of AMPK in neonatal cardiac myocytes or depletion of AMPK␣2 in KO mice. This suggested that AMPK␣2 plays an important role in regulating myocardial energy metabolism-related gene expression. Interestingly, a similar set of genes was downregulated in the AMPK␣2-deficient hearts as those observed in the global ERR␣-deficient hearts. 7, 8 Furthermore, the changes in expression of these energy metabolism-related genes in the AMPK␣2 KO mice or rat neonatal cardiac myocytes were associated with changes in the expression of ERR␣. Most importantly, in the AMPK␣2-deficient neonatal cardiac myocytes, overexpression of either ERR␣ or constitutively active AMPK␣ rescued the repressed expression of VLCAD and MCAD. These results imply that AMPK␣2 regulates energy metabolismrelated genes at least partially through ERR␣. CPT1b has been reported as a target gene for both ERR␣ and ERR␥, 7, 31 and a potential ERR responsive element was identified in its promoter. 1 ERR␣ has been shown to regulate the expression of CPT1b in mouse embryonic fibroblasts 26, 32 and brown adipose tissue. 33 However, the expression of CPT1b was not changed in ERR␣-deficient hearts but was decreased in the ERR␥ KO hearts. Therefore, in the heart, ERR␥, but not ERR␣, appears to play the dominant role in the regulation of CPT1b expression. In the current study, we found that depletion of AMPK␣2 in rat neonatal cardiac myocytes or in the heart tissue of AMPK␣2 KO mice repressed CPT1b expression, whereas activation of AMPK induced CPT1b in rat neonatal cardiac myocytes. However, in the AMPK␣2-deficient neonatal cardiac myocytes, overexpression of ERR␣ did not rescue CPT1b expression, indicating that the decreased expression of ERR␣ in these cells is not directly responsible for the downregulation of CPT1b. These findings imply that the reduced ERR␣ expression in the AMPK␣2 KO mice contributed to the dysregulation of only some of the energy metabolismrelated genes. Changes of other transcription factors, such as ERR␥, might also contribute to the phenotypes observed in AMPK␣2 KO mice. Intriguingly, in the wild-type cells, overexpression of ERR␣ led to different responses in the expression of its potential targets. The function of ERR␣ is modulated by its coregulators, such as coactivators PGC-1␣/␤ and corepressor RIP140. Thus, in some cases, ERR␣ overexpression caused significant increases of its responsive genes, 32, 34 but in several other studies, overexpression of ERR␣ alone failed to induce some of those target genes. 6, 35, 36 These results suggest that the ratio of ERR␣ and its coactivators may be critical for its target gene activation and that this effect seems to be gene specific. On the other hand, overexpressed ERR␣ may induce expression of corepressors, such as RIP140 37 and SHP, 38 which forms a negative feedback loop and represses gene expression. 39 Furthermore, ERR␣ may compete for coactivators with other transcription factors, which, in turn, could result in gene repression. 11 Similar to our observations in AMPK␣2 KO mice, several recent studies have demonstrated that moderate decreases of the myocardial energy metabolism-related genes caused no apparent LV dysfunction in mice with disruption of ERR␣, 8 PGC-1␣, 18, 40 or PGC-1␤ 41 mice or cardiac K ATP channel activity 21 under unstressed conditions. Nevertheless, disruption of AMPK␣2, 16 ERR␣, 8 PGC-1␣ 42 or cardiac K ATP channel activity 21 all significantly exacerbated TAC-induced LV hypertrophy and heart failure. Thus, a moderate decrease of energy metabolism related genes that has no effect on LV function under unstressed conditions may compromise the myocardial energy reserve and impair the cardiac adaptation to hemodynamic stresses, such as chronic systolic pressure overload.
Clinical Perspectives
Myocardial mitochondrial enzymes are essential to maintain the cardiac energy reserve and to facilitate adaptive responses to stress, but the underlying molecular mechanisms for maintaining myocardial mitochondrial enzyme expression have been elusive. We demonstrated that the expression level of ERR␣, but not PGC-1␣, correlates with the downregulation of cardiac energyproducing enzymes in myocardium from both patients and mice with heart failure. These results imply that PGC-1␣-independent pathway(s) can regulate myocardial energetics, which might involve ERR␣. We further demonstrated that AMPK␣2 (but not AMPK␣1) regulates ERR␣ expression in cardiac myocytes. Our data support an important role for AMPK␣2 in regulating the expression of myocardial ERR␣ and its downstream mitochondrial enzymes. These results suggest that treatments that increase AMPK activity may have potential therapeutic value in heart failure. Table S1 . General information of the human subjects. +  +  +  +  +  +  ----+  +  +  +  --------+  +  --+  +  --+  +  --+  +  +  +  +  +  +  +  ----+  +  +  +  --------+  +  --+  +  --+  + Figure S4 . Effects of AMPK and ERRα overexpression on oxidative stress damage in rat neonatal cardiac myocytes. Rat neonatal cardiac myocytes were treated with H 2 O 2 or vehicle. Inhibition of AMPKα2 expression by specific siRNA decreased cell viability (A), increased the level of cleaved caspase 3 (B) and the number of TUNEL positive cells (C). The enhanced oxidative stress damage caused by AMPKα2 repression could be partially rescued by ERRα overexpression.
